Please login to the form below

Not currently logged in
Email:
Password:

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

edit-Otmar-D-WiestlerGermany-based Bayer has appointed Otmar Wiestler to its supervisory board with immediate effect.

Since January 2004 Wiestler has been chairman of Bayer's management board and scientific director of the German cancer research centre in Heidelberg, Germany. He has also been chairman of the advisory committee and a member of the board of German Cancer Aid.

In addition to these roles, he served in the executive committee of the Helmholtz Association from 2007 to 2012.

Wiestler succeeds Klaus Kleinfeld, who left the position in September in order to concentrate on other office and honorary posts, some of which are located in the US.

In regards to the appointment, Werner Wenning, chairman of Bayer's supervisory board, said: “We would like to thank Mr Kleinfeld for our very successful and trusting cooperation. In Prof Wiestler we have found a competent successor with extensive scientific expertise.”

9th October 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics